Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag in ITP Refractory to Eltrombopag or Herombopag
NCT04993885Phase 2Recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Sep 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in immune thrombocytopenia (ITP), Evans syndrome, sponsored by Institute of Hematology and Blood Diseases Hospital. Started Sep 2021; status: recruiting.
02
Drugs
avatrombopag
03
Conditions
immune thrombocytopenia (ITP)Evans syndrome
Beyond the preview
Go deeper on NCT04993885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04993885.